Clinical Trials Browser

INDUSTRY × Carcinoma, Hepatocellular × Fluorouracil × Clear all

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT02069041 2018-11-21

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Phase 1 Completed

8 enrolled 16 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01489566 2011-12-14

Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00559455 2011-06-28

Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00471965 2010-09-20

EACH

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00644020 2008-03-26

Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence